Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.61 USD
−69.13 M USD
0.00 USD
30.71 M
About Tyra Biosciences, Inc.
Sector
Industry
CEO
Todd J. Harris
Website
Headquarters
Carlsbad
Founded
2018
FIGI
BBG00RCQD9D1
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TYRA is 13.72 USD — it has decreased by −2.49% in the past 24 hours. Watch Tyra Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tyra Biosciences, Inc. stocks are traded under the ticker TYRA.
TYRA stock has fallen by −1.72% compared to the previous week, the month change is a −14.30% fall, over the last year Tyra Biosciences, Inc. has showed a −5.90% decrease.
We've gathered analysts' opinions on Tyra Biosciences, Inc. future price: according to them, TYRA price has a max estimate of 33.00 USD and a min estimate of 29.00 USD. Watch TYRA chart and read a more detailed Tyra Biosciences, Inc. stock forecast: see what analysts think of Tyra Biosciences, Inc. and suggest that you do with its stocks.
TYRA reached its all-time high on Nov 4, 2021 with the price of 31.36 USD, and its all-time low was 4.93 USD and was reached on Jun 21, 2022. View more price dynamics on TYRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TYRA stock is 6.02% volatile and has beta coefficient of 2.44. Track Tyra Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tyra Biosciences, Inc. there?
Today Tyra Biosciences, Inc. has the market capitalization of 743.91 M, it has decreased by −2.96% over the last week.
Yes, you can track Tyra Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Tyra Biosciences, Inc. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
TYRA earnings for the last quarter are −0.41 USD per share, whereas the estimation was −0.40 USD resulting in a −2.82% surprise. The estimated earnings for the next quarter are −0.49 USD per share. See more details about Tyra Biosciences, Inc. earnings.
Tyra Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TYRA net income for the last quarter is −24.02 M USD, while the quarter before that showed −18.70 M USD of net income which accounts for −28.41% change. Track more Tyra Biosciences, Inc. financial stats to get the full picture.
No, TYRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 49.00 employees. See our rating of the largest employees — is Tyra Biosciences, Inc. on this list?
Like other stocks, TYRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tyra Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tyra Biosciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tyra Biosciences, Inc. stock shows the strong sell signal. See more of Tyra Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.